HI-TECH PHARMACAL INC
HITK
HITK was delisted on the 16th of April, 2014.
101 hedge funds and large institutions have $397M invested in HI-TECH PHARMACAL INC in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 38 reducing their positions, and 16 closing their positions.
4% less capital invested
Capital invested by funds: $414M → $397M (-$16.9M)
5% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 38
4% less funds holding
Funds holding: 105 → 101 (-4)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
65% less call options, than puts
Call options by funds: $521K | Put options by funds: $1.49M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
+$12.4M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$9.47M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$8.41M |
| 4 |
Goldman Sachs
New York
|
+$2.41M |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
+$2.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$16.3M |
| 2 |
Millennium Management
New York
|
-$13.8M |
| 3 |
WIC
Water Island Capital
New York
|
-$8.47M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.92M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
-$6.27M |
HITK Hedge Fund Activity: Q4 2013 in Review
101 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in HI-TECH PHARMACAL INC (HITK) for Q4 2013, worth a combined $397M — down 4.1% from $414M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of HITK and 12 opened new positions — a net loss of 4 holders — while 38 trimmed existing stakes and 36 added.
The largest buyer was Longfellow Investment Management, adding an estimated $12.4M. The largest seller was BlackRock Institutional Trust, cutting an estimated $16.3M.
- 101 institutional investors held HI-TECH PHARMACAL INC (HITK) as of Q4 2013, down from 105 in Q3 2013.
- Funds reported $397M of HI-TECH PHARMACAL INC stock for Q4 2013, down 4.1% quarter-over-quarter.
- 12 funds opened new HI-TECH PHARMACAL INC positions in Q4 2013 and 16 closed out, a net change of -4 holders.
- The largest HI-TECH PHARMACAL INC buyer in Q4 2013 was Longfellow Investment Management, an estimated $12.4M added.
- The largest HI-TECH PHARMACAL INC seller in Q4 2013 was BlackRock Institutional Trust, an estimated $16.3M sold.
Based on aggregated 13F filings for Q4 2013.